Structural Biology in Drug Design

Drug design is an innovative process to asset new medication based on the knowledge of biological target. Drug is most commonly a small molecule that inhibits or activates the function of a biomolecule, which in turn outcomes in a therapeutic benefit to the patient. Drug design commonly but not essentially relies on computational techniques. This type of modelling is often mentioned to as computer-aided drug design. Drug design that depends on the knowledge of the 3D structure of the target is known as structure-based drug design. The main methods available for drug design are structure based drug design and ligand based drug design.

  • Drug targets
  • Computer-aided drug design
  • Ligand-based design
  • Structure-based design
  • Binding site identification
  • Scoring functions

Related Conference of Structural Biology in Drug Design

October 18-19, 2017

10th Annual Chemistry Congress

Osaka, Japan
October 30 - 31, 2017

3rd International Conference on Transcriptomics

Bangkok, Thailand
November 8-9, 2017

International Summit on Nanotechnology and Medical Robots

New Orleans, Louisiana, USA
November 13-14, 2017

9th International Conference on Bioinformatics

Paris, France
March 12-14, 2018

Glycobiology Biochem Conference 2018

Paris, France
August 06-07, 2018

18th International Conference on Pediatrics Health

Madrid, Spain
September 17-19, 2018

4th Glycobiology World Congress

Rome, Italy
September 24-26, 2018

14th International Conference on Structural Biology

Berlin, Germany

Structural Biology in Drug Design Conference Speakers

Recommended Sessions

Related Journals

Are you interested in